Empowered Funds’s XBiotech XBIT Stock Holding History

Empowered Funds’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$140K	Hold	59,547	–	–	﹤0.01%	2056
2025 Q4	$142K	Hold	59,547	–	–	﹤0.01%	958
2025 Q3	$158K	Buy	59,547 +221	+0.4%	+$654	﹤0.01%	1753
2025 Q2	$176K	Sell	59,326 -1,306	-2%	-$3.8K	﹤0.01%	1663
2025 Q1	$196K	Buy	60,632 +1,043	+2%	+$3.6K	﹤0.01%	1513
2024 Q4	$235K	Sell	59,589 -2,962	-5%	-$20.2K	﹤0.01%	1462
2024 Q3	$484K	Sell	62,551 -6,586	-10%	-$43.3K	0.01%	1100
2024 Q2	$355K	Buy	69,137 +4,860	+8%	+$37.5K	0.01%	1157
2024 Q1	$523K	Buy	64,277 +4,725	+8%	+$27.1K	0.01%	1071
2023 Q4	$238K	Buy	59,552 +5,352	+10%	+$21.3K	0.01%	1169
2023 Q3	$223K	Buy	54,200 +4,424	+9%	+$22.1K	0.01%	1122
2023 Q2	$296K	Buy	+49,776	New	+$225K	0.01%	966

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Empowered Funds's XBIT Position: Q1 2026 in Review

Empowered Funds held its XBiotech (XBIT) position steady in Q1 2026 at 59,547 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

Empowered Funds first reported a position in XBIT in Q2 2023 and has held it in 12 quarters since. The position peaked at $523K in Q1 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

Empowered Funds held 59,547 shares of XBiotech worth $140K as of Q1 2026.
Empowered Funds left its XBiotech share count unchanged in Q1 2026.
XBiotech made up ﹤0.01% of Empowered Funds's portfolio in Q1 2026, its #2056 holding.
Empowered Funds first reported a position in XBiotech in Q2 2023 and has held it in 12 quarters since.
Empowered Funds's XBiotech position peaked at $523K in Q1 2024.
37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.